JGH Open
(Jul 2021)
Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
- Yasuyuki Tamai,
- Motoh Iwasa,
- Akiko Eguchi,
- Ryuta Shigefuku,
- Yoshihiro Kamada,
- Eiji Miyoshi,
- Yoshiyuki Takei
Affiliations
- Yasuyuki Tamai
- Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan
- Motoh Iwasa
- Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan
- Akiko Eguchi
- Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan
- Ryuta Shigefuku
- Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan
- Yoshihiro Kamada
- Department of Molecular Biochemistry and Clinical Investigation Osaka University Graduate School of Medicine Osaka Japan
- Eiji Miyoshi
- Department of Molecular Biochemistry and Clinical Investigation Osaka University Graduate School of Medicine Osaka Japan
- Yoshiyuki Takei
- Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Japan
- DOI
-
https://doi.org/10.1002/jgh3.12596
- Journal volume & issue
-
Vol. 5,
no. 7
pp.
827
– 830
WeChat QR code
